Catatonia Associated With a SCN2A-Related Disorder in a 4-Year-Old Child
- 1 November 2018
- journal article
- research article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 142 (5) , e20181231
Abstract
Catatonia is a rare, underdiagnosed syndrome in children. We report the case of a 4-year-old child admitted for recent social withdrawal alternating with psychomotor excitement, verbigeration, and a loss of toilet readiness. He had a history of neonatal seizures, had been stabilized with vigabatrin, and was seizure free without treatment for several months. The pediatric and psychiatric examination revealed motor stereotypes, mannerism, bilateral mydriasis, and visual hallucinations. Laboratory and brain imaging explorations were initially negative. Catatonic symptoms, as measured with the Pediatric Catatonia Rating Scale, significantly decreased after introducing lorazepam, the first-line recommended treatment of this condition. On the basis of the neonatal seizure history, complementary genetic investigations were performed and revealed a mutation in the SCN2A gene, which encodes the voltage-gated sodium channel Nav1.2. Catatonic symptoms progressively disappeared after reintroducing vigabatrin. At the syndromic level, catatonia in young children appears responsive to high-dose lorazepam and is well monitored by using the Pediatric Catatonia Rating Scale. This case reveals the need for wide-ranging explorations in early-onset catatonia because specific targeted treatments might be available.Keywords
This publication has 26 references indexed in Scilit:
- Clinical spectrum of SCN2A mutations expanding to Ohtahara syndromeNeurology, 2013
- Rediscovering catatonia: the biography of a treatable syndromeActa Psychiatrica Scandinavica, 2012
- Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigensJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Medical and developmental risk factors of catatonia in children and adolescents: A prospective case–control studySchizophrenia Research, 2012
- Successful treatment of two paediatric cases of anti-NMDA receptor encephalitis with Cyclophosphamide: The need for early aggressive immunotherapy in tumour negative paediatric patientsEuropean Journal of Paediatric Neurology, 2012
- Mechanism of action of vigabatrin: correcting misperceptionsActa Neurologica Scandinavica, 2011
- The study of pediatric catatonia supports a home of its own for catatonia in DSM-5Medical Hypotheses, 2010
- Anti–N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis in children and adolescentsAnnals of Neurology, 2009
- ECT for Catatonia in an Autistic GirlAmerican Journal of Psychiatry, 2008
- Rating catatonia in patients with chronic schizophrenia: Rasch analysis of the Bush–Francis Catatonia Rating ScaleInternational Journal of Methods in Psychiatric Research, 2007